Follow
Richard Mark England
Richard Mark England
Associate Director, AstraZeneca PLC UK
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
Hyper/highly-branched polymers by radical polymerisations
RM England, S Rimmer
Polymer Chemistry 1 (10), 1533-1544, 2010
1032010
Combined polymer-curcumin conjugate and ependymal progenitor/stem cell treatment enhances spinal cord injury functional recovery
R Requejo-Aguilar, A Alastrue-Agudo, M Cases-Villar, E Lopez-Mocholi, ...
Biomaterials 113, 18-30, 2017
802017
Endocytic profiling of cancer cell models reveals critical factors influencing LNP-mediated mRNA delivery and protein expression
EJ Sayers, SE Peel, A Schantz, RM England, M Beano, SM Bates, ...
Molecular Therapy 27 (11), 1950-1962, 2019
712019
Well-defined star-shaped polyglutamates with improved pharmacokinetic profiles as excellent candidates for biomedical applications
A Duro-Castano, RM England, D Razola, E Romero, M Oteo-Vives, ...
Molecular Pharmaceutics 12 (10), 3639-3649, 2015
662015
Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers
RM England, JI Hare, J Barnes, J Wilson, A Smith, N Strittmatter, ...
Journal of Controlled Release 247, 73-85, 2017
402017
Synthesis and characterization of dendrimer-based polysarcosine star polymers: Well-defined, versatile platforms designed for drug-delivery applications
RM England, JI Moss, A Gunnarsson, JS Parker, MB Ashford
Biomacromolecules 21 (8), 3332-3341, 2020
342020
Functional Graft Poly (N‐isopropyl acrylamide) s Using Reversible Addition‐Fragmentation Chain Transfer (RAFT) Polymerisation
SR Carter, RM England, BJ Hunt, S Rimmer
Macromolecular bioscience 7 (8), 975-986, 2007
322007
Polyacetal-stilbene conjugates—The first examples of polymer therapeutics for the inhibition of HIF-1 in the treatment of solid tumours
RM England, E Masiá, V Giménez, R Lucas, MJ Vicent
Journal of controlled release 164 (3), 314-322, 2012
262012
Precise and systematic end group chemistry modifications on PAMAM and poly (l-lysine) dendrimers to improve cytosolic delivery of mRNA
F Joubert, MJ Munson, A Sabirsh, RM England, M Hemmerling, ...
Journal of Controlled Release 356, 580-594, 2023
212023
Highway to success—developing advanced polymer therapeutics
MB Ashford, RM England, N Akhtar
Advanced Therapeutics 4 (5), 2000285, 2021
212021
Enhanced cytocompatibility and functional group content of poly (l-lysine) dendrimers by grafting with poly (oxazolines)
RM England, JI Hare, PD Kemmitt, KE Treacher, MJ Waring, ST Barry, ...
Polymer Chemistry 7 (28), 4609-4617, 2016
212016
Polyacetal‐Based Combination Therapy for the Treatment of Prostate Cancer
T Plyduang, A Armiñán, J Movellan, RM England, R Wiwattanapatapee, ...
Macromolecular Rapid Communications 39 (19), 1800265, 2018
112018
Evolution of nanomedicine formulations for targeted delivery and controlled release
S Puri, M Mazza, G Roy, RM England, L Zhou, S Nourian, JA Subramony
Advanced Drug Delivery Reviews, 114962, 2023
102023
Investigating the properties of l-lysine dendrimers through physico-chemical characterisation techniques and atomistic molecular dynamics simulations
RM England, S Sonzini, D Buttar, KE Treacher, MB Ashford
Polymer Chemistry 13 (18), 2626-2636, 2022
102022
Designing highly stable poly (sarcosine)-based telodendrimer micelles with high drug content exemplified with fulvestrant
Q Yu, RM England, A Gunnarsson, R Luxenhofer, K Treacher, MB Ashford
Macromolecules 55 (2), 401-412, 2022
92022
Synthesis of chain end functionalized linear and branched polymers by radical polymerisation in the presence of a silyl enol
RM England, S Rimmer
Chemical communications 46 (31), 5767-5769, 2010
82010
Evaluating liver uptake and distribution of different poly (2-methyl-2-oxazoline) modified lysine dendrimers following intravenous administration
RM England, JI Moss, KJ Hill, K Elvevold, B Smedsrød, MB Ashford
Biomaterials science 7 (8), 3418-3424, 2019
52019
Method to investigate the distribution of water-soluble drug-delivery systems in fresh frozen tissues using imaging mass cytometry
N Strittmatter, RM England, AM Race, D Sutton, JI Moss, G Maglennon, ...
Analytical Chemistry 93 (8), 3742-3749, 2021
42021
Controlled Synthesis of Polyglutamates with Low Polydispersity and Versatile Architectures
V Docon, M Jesus, M Barz, F Canal, I Conejos Sanchez, A Duro Castano, ...
US Patent 20,150,087,788, 2015
42015
Drug delivery strategies: Polymer therapeutics
RM England, I Conejos–sánchez
32012
The system can't perform the operation now. Try again later.
Articles 1–20